Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r)-9-(2-phosphonylmethoxypropyl)adenine
2. 9-(2-phosphonylmethoxypropyl)adenine
3. 9-(2-phosphonylmethoxypropyl)adenine, (+-)-isomer
4. 9-(2-phosphonylmethoxypropyl)adenine, (r)-isomer - T357098
5. 9-(2-phosphonylmethoxypropyl)adenine, (s)-isomer
6. 9-pmpa (tenofovir)
7. Disoproxil Fumarate, Tenofovir
8. Disoproxil, Tenofovir
9. Fumarate, Tenofovir Disoproxil
10. Tenofovir
11. Tenofovir Disoproxil
12. Tenofovir Disoproxil Fumarate
13. Viread
1. 107021-12-5
2. Tenofovir-d6
3. Apropovir
4. 1-(6-aminopurin-9-yl)propan-2-yloxymethylphosphonic Acid
5. (((1-(6-amino-9h-purin-9-yl)propan-2-yl)oxy)methyl)phosphonic Acid
6. ({[1-(6-amino-9h-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic Acid
7. 1217720-14-3
8. Tenofovir (parent)
9. Mfcd21604708
10. ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phosphonic Acid
11. Mls006011450
12. Schembl497725
13. Chembl315593
14. Dtxsid30861388
15. Bcp02416
16. Vqb71994
17. Bbl032950
18. Stl370337
19. 9-[2-(phosphonomethoxy)propyl]adenine
20. Akos015961830
21. Phosphonic Acid, ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-
22. Smr004703253
23. Sy115900
24. Ft-0601652
25. Ft-0674851
26. Ft-0696939
27. 9-[2-(phosphonomethoxy)propyl]-9h-purin-6-amine
28. A851347
29. (r)-pmpa;gs-1278;gs 1278;gs1278;tdf;pmpa
30. (s)-[[[1-(6-amino-9h-purin-9-yl)-2-propyl]oxy]methyl]phosphonic Acid
Molecular Weight | 287.21 g/mol |
---|---|
Molecular Formula | C9H14N5O4P |
XLogP3 | -1.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 287.07834094 g/mol |
Monoisotopic Mass | 287.07834094 g/mol |
Topological Polar Surface Area | 136 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 354 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-HIV Agents
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)
Reverse Transcriptase Inhibitors
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
A Apropovir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apropovir, including repackagers and relabelers. The FDA regulates Apropovir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apropovir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Apropovir supplier is an individual or a company that provides Apropovir active pharmaceutical ingredient (API) or Apropovir finished formulations upon request. The Apropovir suppliers may include Apropovir API manufacturers, exporters, distributors and traders.
click here to find a list of Apropovir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Apropovir DMF (Drug Master File) is a document detailing the whole manufacturing process of Apropovir active pharmaceutical ingredient (API) in detail. Different forms of Apropovir DMFs exist exist since differing nations have different regulations, such as Apropovir USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Apropovir DMF submitted to regulatory agencies in the US is known as a USDMF. Apropovir USDMF includes data on Apropovir's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Apropovir USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Apropovir suppliers with USDMF on PharmaCompass.
Apropovir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Apropovir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apropovir GMP manufacturer or Apropovir GMP API supplier for your needs.
A Apropovir CoA (Certificate of Analysis) is a formal document that attests to Apropovir's compliance with Apropovir specifications and serves as a tool for batch-level quality control.
Apropovir CoA mostly includes findings from lab analyses of a specific batch. For each Apropovir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Apropovir may be tested according to a variety of international standards, such as European Pharmacopoeia (Apropovir EP), Apropovir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apropovir USP).
LOOKING FOR A SUPPLIER?